Akcea Therapeutics

AT a medicine development and commercialization company, focuses on helping patients with serious cardiometabolic lipid disorders.

Akcea Therapeutics, a subsidiary of Ionis Pharmaceuticals, Inc., is a development and commercialization company focused on transforming serious cardiometabolic lipid disorders. Akcea's portfolio spans multiple targets and disease states, including both rare and more common lipid disorders, using advanced RNA-targeted antisense therapeutics.